APα-induced reduction of AD pathology burden is also consistent with the findings of Mellon and colleagues who reported that APα delayed progression of Niemann-Pick C Disease in a mouse model [23], [52], [53]. This evidence concerns the gene ENPEP and Alzheimer disease.